ISRCTN88921234Completed未知
Identification of metabolomic biomarkers to assess dietary exposure in free-living adults
ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)0 sites51 target enrollmentStarted: April 3, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 51
Study Overview
Brief Summary
2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33195362/ (added 18/11/2021)
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Age 18-80
- •2. Male or female
- •3. Normal weight or overweight (body mass index 18.5-29.9 kg/m2)
Exclusion Criteria
- •1. Weight change of more than 3kg in the preceding 2 months
- •2. Current smokers
- •3. Substance abuse
- •4. Excess alcohol intake
- •5. Pregnancy
- •6. Diabetes (Type 1 and Type 2)
- •7. Cardiovascular disease
- •9. Gastrointestinal disease e.g. inflammatory bowel disease or irritable bowel syndrome
- •10. Kidney disease
- •11. Liver disease
- •12. Pancreatitis
- •13. Food allergy
- •14. Use of medications likely to interfere with energy metabolism, appetite regulation and hormonal imbalance, including but not exclusive to: antiinflammatory drugs (NSAIDs), steroids or other immunosuppressive medication, androgens, phenytoin, erythromycin or thyroid hormones
- •Subjects with the above conditions/taking the above medications would have an altered pattern of hormones and inflammatory molecules because of their disease process which may lead to misleading results.
Investigators
Similar Trials
Completed
Not Applicable
Dietary biomarker discovery using metabolomicsTopic: Primary Care Research Network for EnglandSubtopic: Not AssignedDisease: All DiseasesISRCTN43087333Imperial College Healthcare NHS Trust (UK)19
Active, not recruiting
Not Applicable
Towards the assessment of metabolic biomarkers and creatine uptake and turnover in skeletal muscles of patients with Facioscapulohumeral muscular dystrophy using MR spectroscopy - Assessment of biomarkers in FSHDHealthy volunteers. Later the protocol will be applied to Facioscapular humeral dystrophy and/or other muscular dystrophies in general.MedDRA version: 8.1Level: LLTClassification code 10011328Term: CreatineEUCTR2006-006776-37-NLRadboud University Nijmegen Medical Center
Not yet recruiting
Phase 2
Towards the assessment of metabolic biomarkers and creatine uptake and turnover in skeletal muscles of patients with Facioscapulohumeral muscular dystrophy using MR spectroscopymuscle diseasemuscular dystrophy10028302NL-OMON30391niversitair Medisch Centrum Sint Radboud35
Completed
Not Applicable
Biomarkers of Prednisolone Treatment (P05888)Glucose IntoleranceInsulin ResistanceHyperglycemiaNCT00971724Merck Sharp & Dohme LLC72
Unknown
Not Applicable
Peritoneal Membrane Dysfunction in Peritoneal Dialysis Using MetabolomicsEnd Stage Renal DiseaseDialysisNCT03964701Baxter (Hellas) Ltd18